1. Home
  2. TOVX vs NXU Comparison

TOVX vs NXU Comparison

Compare TOVX & NXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOVX
  • NXU
  • Stock Information
  • Founded
  • TOVX 2001
  • NXU 2016
  • Country
  • TOVX United States
  • NXU United States
  • Employees
  • TOVX N/A
  • NXU N/A
  • Industry
  • TOVX Biotechnology: Pharmaceutical Preparations
  • NXU Automotive Aftermarket
  • Sector
  • TOVX Health Care
  • NXU Consumer Discretionary
  • Exchange
  • TOVX Nasdaq
  • NXU Nasdaq
  • Market Cap
  • TOVX 3.5M
  • NXU 2.9M
  • IPO Year
  • TOVX 2006
  • NXU 2022
  • Fundamental
  • Price
  • TOVX $1.21
  • NXU $0.23
  • Analyst Decision
  • TOVX Strong Buy
  • NXU
  • Analyst Count
  • TOVX 1
  • NXU 0
  • Target Price
  • TOVX $6.00
  • NXU N/A
  • AVG Volume (30 Days)
  • TOVX 102.1K
  • NXU 376.8K
  • Earning Date
  • TOVX 11-12-2024
  • NXU 11-13-2024
  • Dividend Yield
  • TOVX N/A
  • NXU N/A
  • EPS Growth
  • TOVX N/A
  • NXU N/A
  • EPS
  • TOVX N/A
  • NXU N/A
  • Revenue
  • TOVX N/A
  • NXU $396,000.00
  • Revenue This Year
  • TOVX N/A
  • NXU N/A
  • Revenue Next Year
  • TOVX N/A
  • NXU N/A
  • P/E Ratio
  • TOVX N/A
  • NXU N/A
  • Revenue Growth
  • TOVX N/A
  • NXU 238.46
  • 52 Week Low
  • TOVX $1.14
  • NXU $0.21
  • 52 Week High
  • TOVX $17.00
  • NXU $4.95
  • Technical
  • Relative Strength Index (RSI)
  • TOVX 37.37
  • NXU 37.86
  • Support Level
  • TOVX $1.15
  • NXU $0.22
  • Resistance Level
  • TOVX $1.34
  • NXU $0.25
  • Average True Range (ATR)
  • TOVX 0.07
  • NXU 0.02
  • MACD
  • TOVX 0.01
  • NXU 0.00
  • Stochastic Oscillator
  • TOVX 7.41
  • NXU 12.17

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

About NXU Nxu Inc.

Nxu Inc is a technology company developing next-generation electric vehicle (EV) charging, battery, and vehicle technologies for mobility customers. Its technology company building energy and infrastructure solutions for consumers and businesses. Its NxuOne charging technology provides repeatable, consistent power delivery, designed to meet the needs of today's electric vehicles as well as those developed in the future.

Share on Social Networks: